Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing induction chemotherapy with cisplatin and 5-FU with or without docetaxel in patients with T3-T4 laryngeal and hypopharyngeal cancers h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • CISPLATIN (cisplatin)
  • DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Larynx Cancer, Hypopharynx Cancer | Phase 3 | Status: COMPLETED